期刊文献+

基于网络药理学探讨中药调控肿瘤相关性细胞胀亡用药规律 被引量:1

Medication Laws of Chinese Materia Medica in Regulating Tumor-associated Oncosis Based on Network Pharmacology
下载PDF
导出
摘要 目的探讨中药调控肿瘤相关性细胞胀亡的物质基础及用药规律。方法通过检索KEGG、GeneCards、OMIM数据库获取细胞胀亡的作用靶点,以类药性≥0.18为条件,通过中药系统药理学数据库与分析平台(TCMSP)筛选出可作用于靶点的化合物及中药,并构建靶点-化合物、化合物-中药、靶点-化合物-中药网络。依据2015年版《中华人民共和国药典》及《中药学》确定药物的性味归经,分析用药规律。结果共获得34个可作用于细胞胀亡的靶点,可匹配到候选化合物的靶点11个,得到70个候选化合物和324味中药。可干预细胞胀亡的药味以苦、甘、辛为主,药性以寒居多,主要归肝、肺、胃经。结论本研究较系统地探讨了中药干预肿瘤相关性细胞胀亡的物质基础,总结了相关中药的一般规律,可为中西医结合临床及干预细胞胀亡相关中药新药研发提供思路和依据。 Objective To investigate the material basis and medication laws of Chinese materia medica in regulating tumor-associated oncosis. Methods The targets of oncosis were obtained by searching the KEGG, GeneCards, and OMIM. On the condition of drug-like property(DL) ≥ 0.18, compounds and Chinese materia medica acting on the targets were selected from the TCMSP, and the target-compound, compound-Chinese materia medica, target-compound-Chinese materia medica networks were constructed. According to Chinese Pharmacopoeia and Chinese Materia Medica, property, taste and meridian tropism of each Chinese materia medica were identified, and the medication laws were analyzed. Results A total of 34 targets for oncosis were obtained, among which 11 targets were matched to compounds. 70 candidate compounds and 324 kinds of Chinese materia medica were obtained. The results of frequency statistics showed that bitter, sweet and pungent were the main properties which could interfere oncosis, the tastes were mainly cold, and the meridian tropism belonged to liver, lung and stomach. Conclusion This study systematically explores the material basis of TCM intervention in tumor-associated oncosis, summarizes the general rules of Chinese materia medica, and provides ideas and basis for the future clinical application of integrated traditional Chinese and Western medicine and the development of new TCM medicine for intervention in cell oncosis.
作者 许博文 李杰 但文超 李释心 吴静远 曹璐畅 卢泰成 XU Bowen;LI Jie;DAN Wenchao;LI Shixin;WU Jingyuan;CAO Luchang;LU Taicheng(Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China;Graduate School of Beijing University of Chinese Medicine,Beijing 100029,China)
出处 《中国中医药信息杂志》 CAS CSCD 2021年第2期12-18,共7页 Chinese Journal of Information on Traditional Chinese Medicine
基金 国家自然科学基金(81273946、81473463、81774289) 北京市科技计划(D161100005116004) 北京市科技专项(Z171100001117128) 中国中医科学院基本科研业务费自主选题项目(ZZ11-028)。
关键词 细胞胀亡 网络药理学 恶性肿瘤 物质基础 用药规律 oncosis network pharmacology malignant tumor material basis medication laws
  • 相关文献

参考文献18

二级参考文献222

共引文献474

同被引文献29

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部